Anne Marie Albano
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Anne Marie Albano has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
- Philip C. Kendall
Department of Psychology and Neuroscience, Temple University
5 shared publications - Scott N. Compton
Ann and Robert H. Lurie Children's Hospital of Chicago Chicago Illinois USA
5 shared publications - Boris Birmaher
Department of Psychiatry, Western Psychiatric Institute and Clinic, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
4 shared publications - John Piacentini
Division of Child and Adolescent Psychiatry, Jane & Terry Semel Institute For Neurosciences, University of California, Los Angeles, CA, USA
4 shared publications - Courtney Keeton
Division of Child and Adolescent Psychiatry, Department of Psychiatry and Behavioral Sciences Johns Hopkins University School of Medicine Baltimore Maryland USA
2 shared publications - Elizabeth A. Gosch
Philadelphia College of Osteopathic Medicine Philadelphia PA USA
2 shared publications
Latest Publications
- Open Access
- 13 April 2026
- Published by Association for Computing Machinery (ACM)
- p. 1-26
MIND: Empowering Mental Health Clinicians with Multimodal Data Insights through a Narrative Dashboard
- 13 April 2026
- Published by Association for Computing Machinery (ACM)
- p. 1-26
Open AccessMIND: Empowering Mental Health Clinicians with Multimodal Data Insights through a Narrative Dashboard
- 3 March 2026
- Published by Wiley in Journal of Child Psychology and Psychiatry
- Vol. 67 (8) , 1321-1334
Changes in idiographic coping in youth treated for an anxiety disorder
Background: Youth anxiety disorders are highly prevalent and associated with adverse outcomes. Prior research demonstrated improvement in anxiety symptoms following evidence‐based treatment; however, not all youth experience symptom remission, nor do they consistently maintain gains. We examined idiographic changes in youths' perceived ability to cope with individualized anxiety‐provoking situations from pretreatment to six‐month follow‐up in the Child/Adolescent Anxiety Multimodal Treatment Study. Methods: Youth diagnosed with a principal anxiety disorder ( N = 488; ages 7–17; 50.4% male) were randomized to cognitive‐behavioral therapy (CBT), pharmacotherapy (SRT), combination of CBT and SRT, or pill placebo. Youth's perceived ability to cope (i.e., perceived coping efficacy) was assessed independently using youth self‐reports and caregiver‐reports on the Coping Questionnaire, an idiographic measure with anxiety‐provoking situations individualized to each youth. Changes in perceived coping efficacy were examined across treatment conditions using multilevel models, assessed across six timepoints. Models estimating the quadratic effect of time fit better than models estimating the linear effect. Results: There was a significant interaction between the quadratic effect of time and treatment condition, indicating perceptions of youth coping efficacy increase from pretreatment to six‐month follow‐up, yet at different times across treatment based on treatment condition; this finding was observed per both youth‐ and caregiver‐reports. Perceptions of coping efficacy did not differ based on treatment condition for either informant at pretreatment or six‐month follow‐up; however, post hoc analyses revealed significant differences in perceptions of youth coping efficacy at all interim assessments. Conclusions: Results demonstrate that effective treatments for youth anxiety disorders improved youth‐ and caregiver‐reports of perceived coping with youths' individualized anxiety‐provoking situations. Future efforts could prioritize idiographic assessments to facilitate effective treatments.
- 3 March 2026
- Published by Wiley in Journal of Child Psychology and Psychiatry
- Vol. 67 (8) , 1321-1334
Changes in idiographic coping in youth treated for an anxiety disorder
Background: Youth anxiety disorders are highly prevalent and associated with adverse outcomes. Prior research demonstrated improvement in anxiety symptoms following evidence‐based treatment; however, not all youth experience symptom remission, nor do they consistently maintain gains. We examined idiographic changes in youths' perceived ability to cope with individualized anxiety‐provoking situations from pretreatment to six‐month follow‐up in the Child/Adolescent Anxiety Multimodal Treatment Study. Methods: Youth diagnosed with a principal anxiety disorder ( N = 488; ages 7–17; 50.4% male) were randomized to cognitive‐behavioral therapy (CBT), pharmacotherapy (SRT), combination of CBT and SRT, or pill placebo. Youth's perceived ability to cope (i.e., perceived coping efficacy) was assessed independently using youth self‐reports and caregiver‐reports on the Coping Questionnaire, an idiographic measure with anxiety‐provoking situations individualized to each youth. Changes in perceived coping efficacy were examined across treatment conditions using multilevel models, assessed across six timepoints. Models estimating the quadratic effect of time fit better than models estimating the linear effect. Results: There was a significant interaction between the quadratic effect of time and treatment condition, indicating perceptions of youth coping efficacy increase from pretreatment to six‐month follow‐up, yet at different times across treatment based on treatment condition; this finding was observed per both youth‐ and caregiver‐reports. Perceptions of coping efficacy did not differ based on treatment condition for either informant at pretreatment or six‐month follow‐up; however, post hoc analyses revealed significant differences in perceptions of youth coping efficacy at all interim assessments. Conclusions: Results demonstrate that effective treatments for youth anxiety disorders improved youth‐ and caregiver‐reports of perceived coping with youths' individualized anxiety‐provoking situations. Future efforts could prioritize idiographic assessments to facilitate effective treatments.
- 15 November 2023
- Published by Taylor & Francis in Journal of Asthma
- Vol. 61 (5) , 396-404
Asthma and anxiety in children and adolescents: characteristics and treatment outcomes
ObjectiveThis study (a) examined anxious youth with and without asthma on measures of negative self-talk, parental psychopathology, worry content, physical symptoms, panic symptoms, generalized symptoms, and separation anxiety symptoms, and (b) tested if outpatient CBT or medication were differentially effective in reducing anxiety for youth with asthma and anxiety.MethodsThis secondary analysis separated youth with an anxiety disorder into asthma and non-asthma groups. Youth were also compared on response to treatments (i.e. CBT, sertraline, combined, and placebo).ResultsA total of 488 participants participated in the original study, with an average age of 10 years (SD 2.87). Youth with comorbid asthma and anxiety demonstrated higher rates of negative self-talk. Youth with comorbid asthma and anxiety did not differ from the non-asthma group on measures of physical symptoms, anxiety disorder specific symptoms, parental psychopathology, or worry content. Youth with asthma and anxiety responded similarly to the non-asthma group to treatment across treatment conditions.ConclusionsTreatment was comparably effective for youth with comorbid asthma and anxiety and youth with anxiety. Future research could examine the effects of psychopharmaceuticals on asthma and anxiety comorbidity.
- 15 November 2023
- Published by Taylor & Francis in Journal of Asthma
- Vol. 61 (5) , 396-404
Asthma and anxiety in children and adolescents: characteristics and treatment outcomes
ObjectiveThis study (a) examined anxious youth with and without asthma on measures of negative self-talk, parental psychopathology, worry content, physical symptoms, panic symptoms, generalized symptoms, and separation anxiety symptoms, and (b) tested if outpatient CBT or medication were differentially effective in reducing anxiety for youth with asthma and anxiety.MethodsThis secondary analysis separated youth with an anxiety disorder into asthma and non-asthma groups. Youth were also compared on response to treatments (i.e. CBT, sertraline, combined, and placebo).ResultsA total of 488 participants participated in the original study, with an average age of 10 years (SD 2.87). Youth with comorbid asthma and anxiety demonstrated higher rates of negative self-talk. Youth with comorbid asthma and anxiety did not differ from the non-asthma group on measures of physical symptoms, anxiety disorder specific symptoms, parental psychopathology, or worry content. Youth with asthma and anxiety responded similarly to the non-asthma group to treatment across treatment conditions.ConclusionsTreatment was comparably effective for youth with comorbid asthma and anxiety and youth with anxiety. Future research could examine the effects of psychopharmaceuticals on asthma and anxiety comorbidity.
- 28 April 2023
- Published by Elsevier in Journal of the American Academy of Child & Adolescent Psychiatry
- Vol. 63 (1) , 12-16
Modified Approaches to Treating Anxiety for Children With Visual-Spatial Problems: A Strengths-Based Perspective
- 28 April 2023
- Published by Elsevier in Journal of the American Academy of Child & Adolescent Psychiatry
- Vol. 63 (1) , 12-16
Modified Approaches to Treating Anxiety for Children With Visual-Spatial Problems: A Strengths-Based Perspective
- Open Access
- 17 September 2020
- Published by Elsevier in Journal of the American Academy of Child & Adolescent Psychiatry
- Vol. 60 (7) , 902-912.e5
The p Factor Consistently Predicts Long-Term Psychiatric and Functional Outcomes in Anxiety-Disordered Youth
- 17 September 2020
- Published by Elsevier in Journal of the American Academy of Child & Adolescent Psychiatry
- Vol. 60 (7) , 902-912.e5
Open AccessThe p Factor Consistently Predicts Long-Term Psychiatric and Functional Outcomes in Anxiety-Disordered Youth
- 8 May 2019
- Published by Wiley in Depression and Anxiety
- Vol. 36 (10) , 930-940
Mood and suicidality outcomes 3–11 years following pediatric anxiety disorder treatment
Youth anxiety interventions have potential to reduce risk for depression and suicidality. This naturalistic follow-up of the multi-site, comparative treatment trial, inking and behavior, and depressive symptoms 3-11 years (mean 6.25 years) following 12-week evidence-based youth anxiety treatment. Participants (N = 319; 10-26 years, mean 17 years) completed semiannual questionnaires and annual diagnostic interviews for 4 years. One-fifth (20.4%) of the sample met DSM-IV criteria for a mood disorder, 32.1% endorsed suicidal ideation, and 8.2% reported suicidal behavior. Latent class growth analysis yielded two linear trajectories of depressive symptoms, and 85% of the sample demonstrated a persistent low-symptom course over seven assessments. Child/Adolescent Anxiety Multimodal Study (CAMS) 12-week treatment outcome (positive response, remission) and treatment condition (cognitive behavior therapy [CBT], medication, CBT + medication, pill placebo) were not associated with subsequent mood disorder or suicidal thinking. CAMS remission predicted absence of suicidal behavior, and treatment response and remission predicted low depressive symptom trajectory. Greater baseline self-reported depressive symptoms predicted all long-term mood outcomes, and more negative life events predicted subsequent mood disorder, depressive symptom trajectory, and suicidal ideation. Effective early treatment of youth anxiety, including CBT, medication, or CBT + medication, reduces risk for subsequent chronic depressive symptoms and suicidal behavior. Attention to (sub)clinical depressive symptoms and management of negative life events may reduce odds of developing a mood disorder, chronic depressive symptoms, and suicidality. Findings contribute to evidence that early intervention for a primary disorder can serve as secondary prevention.
- 8 May 2019
- Published by Wiley in Depression and Anxiety
- Vol. 36 (10) , 930-940
Mood and suicidality outcomes 3–11 years following pediatric anxiety disorder treatment
Youth anxiety interventions have potential to reduce risk for depression and suicidality. This naturalistic follow-up of the multi-site, comparative treatment trial, inking and behavior, and depressive symptoms 3-11 years (mean 6.25 years) following 12-week evidence-based youth anxiety treatment. Participants (N = 319; 10-26 years, mean 17 years) completed semiannual questionnaires and annual diagnostic interviews for 4 years. One-fifth (20.4%) of the sample met DSM-IV criteria for a mood disorder, 32.1% endorsed suicidal ideation, and 8.2% reported suicidal behavior. Latent class growth analysis yielded two linear trajectories of depressive symptoms, and 85% of the sample demonstrated a persistent low-symptom course over seven assessments. Child/Adolescent Anxiety Multimodal Study (CAMS) 12-week treatment outcome (positive response, remission) and treatment condition (cognitive behavior therapy [CBT], medication, CBT + medication, pill placebo) were not associated with subsequent mood disorder or suicidal thinking. CAMS remission predicted absence of suicidal behavior, and treatment response and remission predicted low depressive symptom trajectory. Greater baseline self-reported depressive symptoms predicted all long-term mood outcomes, and more negative life events predicted subsequent mood disorder, depressive symptom trajectory, and suicidal ideation. Effective early treatment of youth anxiety, including CBT, medication, or CBT + medication, reduces risk for subsequent chronic depressive symptoms and suicidal behavior. Attention to (sub)clinical depressive symptoms and management of negative life events may reduce odds of developing a mood disorder, chronic depressive symptoms, and suicidality. Findings contribute to evidence that early intervention for a primary disorder can serve as secondary prevention.
- 23 March 2009
- Published by Elsevier in Cognitive and Behavioral Practice
- Vol. 16 (2) , 191-204
From Theory to Practice: Facing Ethical Challenges as a Clinical Intern
- 23 March 2009
- Published by Elsevier in Cognitive and Behavioral Practice
- Vol. 16 (2) , 191-204
From Theory to Practice: Facing Ethical Challenges as a Clinical Intern
- 1 June 2004
- Published by Oxford University Press (OUP)
- p. 198-235
Social Anxiety Disorder
This chapter describes a framework for understanding social anxiety disorder (otherwise called social phobia) that is developmental, multi-factorial, and transactional. Implied in this frame of reference is the view that manifestations of social anxiety disorder vary depending on developmental stage, there are continuities and discontinuities in the expression of social anxiety disorder and its precursors, multiple factors from different domains contribute to the risk of or protection from the development of social anxiety disorder, and interactions between contributory factors may be bidirectional.
- 1 June 2004
- Published by Oxford University Press (OUP)
- p. 198-235
Social Anxiety Disorder
This chapter describes a framework for understanding social anxiety disorder (otherwise called social phobia) that is developmental, multi-factorial, and transactional. Implied in this frame of reference is the view that manifestations of social anxiety disorder vary depending on developmental stage, there are continuities and discontinuities in the expression of social anxiety disorder and its precursors, multiple factors from different domains contribute to the risk of or protection from the development of social anxiety disorder, and interactions between contributory factors may be bidirectional.